PAB 14.3% 0.8¢ patrys limited

Ann: Presentation to highlight broader potential of Deoxymabs, page-41

  1. 7,265 Posts.
    lightbulb Created with Sketch. 943
    It very well could be salty, the next few months is going to set up where we were over 2 yrs ago..

    If the GMP is a successes(let’s just go with that as we all know the other scenario) then this will imho bring in the bigger players to Jv/deal/partner up with DX-3, this is where the early bags will come from well before we get to trials, they will finally be coming out of the woodwork to secure using our IP with theirs

    April 4th could be one of the biggest pitches PAB have and a big one might get to see the pre-limb report of a successful GMP run(NDA signed of course lol)

    The market will tell us long before we will know by the company,
    1c could be so cheap in a short time and as the Dr repeatedly stated now a long time ago”this is not failure but just a delay to the clinic””
    Last edited by mattyedw: 01/04/24
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.001(14.3%)
Mkt cap ! $16.46M
Open High Low Value Volume
0.8¢ 0.8¢ 0.7¢ $23.37K 2.996M

Buyers (Bids)

No. Vol. Price($)
21 6927780 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 996476 4
View Market Depth
Last trade - 15.59pm 07/06/2024 (20 minute delay) ?
Last
0.8¢
  Change
0.001 ( 14.3 %)
Open High Low Volume
0.8¢ 0.8¢ 0.8¢ 2446158
Last updated 15.59pm 07/06/2024 ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.